Margo A. Smith
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
- Emergency Medicine top 10%
- HIV-related health complications and treatments
Papers in
-
- Tuberculosis Research and Epidemiology 2
- HIV/AIDS drug development and treatment 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Infective Endocarditis Diagnosis and Management 2
- Co-authors
- Daniel R. Lucey (5 shared papers)Vee J. Gill (3 shared papers)Peter Kim (2 shared papers)Alice Rosenberg (2 shared papers)Patrick Georgoff (2 shared papers)Colleen Hadigan (2 shared papers)Christian Woods (2 shared papers)Joseph A. Kovacs (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Diagnostic Microbiology and Infectious Disease (1 paper)HIV Medicine (1 paper)The Journal of Clinical Pharmacology (1 paper)Diabetes Care (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Margo A. Smith
14 papers receiving 443 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 259
- Emergency Medicine 96
- Virology 39
- Epidemiology 224
- Endocrinology 18
Countries citing papers authored by Margo A. Smith
This map shows the geographic impact of Margo A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margo A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margo A. Smith more than expected).
Fields of papers citing papers by Margo A. Smith
This network shows the impact of papers produced by Margo A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margo A. Smith. The network helps show where Margo A. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Margo A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 135 | |
| 2 | 2009 | 98 | |
| 3 | 2002 | 38 | |
| 4 | 2010 | 37 | |
| 5 | 2009 | 23 | |
| 6 | 2001 | 23 | |
| 7 | 2011 | 21 | |
| 8 | 2002 | 20 | |
| 9 | 1997 | 19 | |
| 10 | 1990 | 18 | |
| 11 | Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam. | 1990 | 15 |
| 12 | 2020 | 8 | |
| 13 | 1990 | 4 | |
| 14 | 2002 | 1 |
About Margo A. Smith
Margo A. Smith is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Emergency Medicine and Virology, having authored 14 papers that have together received 460 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (3 papers), HIV Research and Treatment (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Infective Endocarditis Diagnosis and Management (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Tuberculosis Research and Epidemiology (2 papers), HIV-related health complications and treatments (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Infectious Diseases (259 citations), Emergency Medicine (96 citations), Virology (39 citations), Epidemiology (224 citations) and Endocrinology (18 citations). Margo A. Smith has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Daniel R. Lucey, Vee J. Gill, Peter Kim, Alice Rosenberg, Patrick Georgoff, Colleen Hadigan, Christian Woods, Joseph A. Kovacs, Janine Maenza and Steven H. Fischer. Their work appears in journals such as Clinical Infectious Diseases, Diagnostic Microbiology and Infectious Disease, HIV Medicine, The Journal of Clinical Pharmacology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.